Cart
sales@molnova.com
Bronidox
CAS No. 30007-47-7
Bronidox( 5-Bromo-5-nitro-1,3-dioxane )
Catalog No. M24223 CAS No. 30007-47-7
Bronidox is an antimicrobial compound that works by inhibiting enzyme activity in bacteria.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | 28 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 61 | In Stock |
|
| 1G | 89 | In Stock |
|
Biological Information
-
Product NameBronidox
-
NoteResearch use only, not for human use.
-
Brief DescriptionBronidox is an antimicrobial compound that works by inhibiting enzyme activity in bacteria.
-
DescriptionBronidox is an antimicrobial compound that works by inhibiting enzyme activity in bacteria.
-
In Vitro——
-
In Vivo——
-
Synonyms5-Bromo-5-nitro-1,3-dioxane
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number30007-47-7
-
Formula Weight212
-
Molecular FormulaC4H6BrNO4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES[O-][N+](C1(COCOC1)Br)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Alvarez-Rivera G , Vila M , Lores M , et al. Development of a multi-preservative method based on solid-phase microextraction–gas chromatography–tandem mass spectrometry for cosmetic analysis[J]. Journal of Chromatography A, 2014, 1339:13-25.
molnova catalog
related products
-
Talacotuzumab
Talacotuzumab (JNJ 56022473) is an IgG1 fully humanized CD123 neutralizing monoclonal antibody containing a modified Fc structure.
-
6,7-Dihydroxybergamo...
6',7'-Dihydroxybergamottin(DHB), a well-known inhibitor of CYP3A4, the inhibition of CYP3A4 activity by DHB includes the inhibition of POR activity, DHB can inhibit nifedipine oxidation in a concentration-dependent manner.
-
NDMC101
NDMC101 is an inhibitor of dipeptidyl peptidase-IV activity in human T cells and exhibits immunomodulatory effects. It also acts as a novel inhibitor of NFATc1 and NF-κB activity.NDMC101 markedly inhibited RANKL-induced formation of TRAP+ multinucleated cells in RAW264.7 and bone marrow macrophage cells (BMMs).?
